The combination of size-based separation and selection-free technology provides higher CTC detection sensitivity than either method alone in patients with metastatic prostate cancer

Authors :: Morgan D. Kuczler
Y.K. Cho
Diane K. Reyes
W. Xue
Liang Dong
Zhongyuan Zhang
K. Smith
Kenneth J. Pienta
Sarah R. Amend
Source :: European Urology Open Science, Vol 19, Iss, Pp e1565-e1566 (2020)
Publication Year :: 2020
Publisher :: Elsevier, 2020.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Urology
Separation (statistics)
medicine.disease
lcsh:Diseases of the genitourinary system. Urology
lcsh:RC870-923
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
lcsh:RC254-282
Prostate cancer
Internal medicine
medicine
In patient
Sensitivity (control systems)
business
Selection (genetic algorithm)

Tools